CVS Health Plans to Separate Drugstore and Insurance Units
CVS Health is considering splitting off its pharmacy business, a move that would unwind its landmark $78 billion Aetna acquisition from 2018.
CVS Health is weighing a major corporate breakup that would separate its retail drugstore operations from its broader healthcare and insurance businesses, according to reports, marking a potential reversal of one of the largest deals in U.S. healthcare history.
The proposed split would effectively unwind the company's $78 billion acquisition of health insurer Aetna, completed in 2018, which was designed to create a vertically integrated healthcare conglomerate spanning pharmacy retail, pharmacy benefits management, and health insurance under a single corporate roof.
Read more Wonder Eyes IPO With Automation and Custom Restaurants in Texas →
The 2018 Aetna deal was billed at the time as a transformative bet on the future of healthcare delivery, with CVS arguing that combining insurance coverage with retail pharmacy access and clinical services would lower costs and improve patient outcomes. A reversal of that strategy would signal that the integrated model has fallen short of investor and operational expectations.
Breaking up the company could allow each business unit to pursue independent strategies, attract specialized investors, and reduce the complexity that has weighed on CVS's stock performance in recent years. Large healthcare conglomerates have faced mounting pressure from Wall Street to streamline operations and demonstrate clearer paths to profitability.
The deliberations underscore a broader reassessment across the U.S. healthcare sector, where several major players have struggled to prove that vertical integration delivers the financial and clinical efficiencies once promised. Continue reading at Business News.
